DIAGNOSTIC VALUE OF CARTILAGE OLIGOMERIC MATRIX PROTEIN IN CONNECTIVE TISSUE DISEASE

Download full text PDF
Issue: 
10
Year: 
2017

Yu. Belova; Professor E. Gladilin, MD V.I. Razumovsky Saratov State Medical University

The paper gives data on the diagnostic value of cartilage oligomeric matrix protein in connective tissue disease. The authors briefly outline the results of their own investigation aimed at determining the level of this protein as a biomarker of cartilage metabolism in children with hip dysplasia.

Keywords: 
cartilage oligomeric matrix protein
connective tissue disease



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Engel's F. Dialektika prirody / M.: Politicheskaja literatura, 1975.
  2. Sokolova O.S. Proteomnye issledovanija v biologii i meditsine. Metodicheskoe posobie / M.: Izd-vo: MGU im. M.V. Lomonosova, 2005.
  3. Andersson M., Svensson B., Petersson I. et al. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis // BMC Musculoskelet Disord. – 2013; 2 (14): 229.
  4. Happonen K., Saxne T., Jacobsson L. et al. COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations // J. Rheumatol. – 2013; 40 (12): 2001–5.
  5. Hidayat R., Isbagio H., Setyohadi B. et al. Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients // Acta Med. Indones. – 2014; 46 (1): 24–9.
  6. Christensen A., Lindegaard H., Horslev-Petersen K. et al. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis // J. Rheumatol. – 2011; 38 (8): 1563–8.
  7. Houseman M., Potter C., Marshall N. et al. Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up // Arthritis Res Ther. – 2012; 14 (1): R30.
  8. Niki Y., Takeuchi T., Nakayama M. et al. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy // PLoS One. – 2012; 7 (5): e37447.
  9. Mobasheri A. Osteoarthritis year 2012 in review: biomarkers // Osteoarthritis Cartilage. – 2012; 20 (12): 1451–64.
  10. Lotz M., Martel-Pelletier J., Christiansen C. et al. Value of biomarkers in osteoarthritis: current status and perspectives // Ann. Rheum. Dis. – 2013; 72 (11): 1756–63.
  11. Wang X., Zheng Y., Cao Y. et al. Study on the diagnostic value of whole-organ magnetic resonance imaging score (WORMS) in knee osteoarthritis // Zhongguo Gu Shang. – 2012; 25 (5): 364–8.
  12. Williams F., Spector T. Biomarkers in osteoarthritis // Arthritis Res. Ther. – 2008; 10 (1): 101.
  13. Li H., Wang D., Wu Z. et al. Serum levels of cartilage oligomeric matrix protein in the diagnosis of knee osteoarthritis // Zhongguo Gu Shang. – 2012; 25 (5): 380–3.
  14. Verma P., Dalal K. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker // J. Orthop. Res. – 2013; 31 (7): 999–1006.
  15. Addison S., Coleman R., Feng S. et al. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation // Arthritis Rheum. – 2009; 60 (11): 3366–73.
  16. Vos L., Kuijer R., Huddleston Slater J. et al. Inflammation is more distinct in temporomandibular joint osteoarthritis compared to the knee joint // J. Maxillofac. Surg. – 2014; 72 (1): 35–40.
  17. Svetlova M.S. Gonartroz rannih stadij: kliniko-instrumental'naja, laboratornaja harakteristika i bolezn'-modifitsirujuschaja terapija. Avtoref. dis. … d-ra med. nauk. Jaroslavl', 2009.
  18. Zivanović S., Rackov L., Zivanović A. Cartilage oligomeric matrix protein – inflammation biomarker in knee osteoarthritis // Bosn. J. Basic Med. Sci. – 2011; 11 (1): 27–32.
  19. Posey K., Hecht J. The role of cartilage oligomeric matrix protein (COMP) in skeletal disease // Curr. Drug Targets. – 2008; 9 (10): 869–77.
  20. Spiridonov N.A. Mediko-sotsial'nye posledstvija u bol'nyh s vrozhdennym vyvihom bedra i sovremennye podhody k ih reabilitatsii. Avtoref. dis. … kand. med. nauk. M., 2011.